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Abstract  20 
G-rich sequences can form alternative DNA secondary structures called G-quadruplexes (G4s). 21 
Substantial evidence now exists to support that formation of G4 structures is related to gene-22 
expression and the case for targeting G4s for therapeutic intervention is getting stronger. 23 
Nevertheless, there is a need to devise additional approaches to study G4s in living cells to build 24 
further understanding on their actual biological relevance. The in-situ observation of G4-25 
formation in living cells would provide evidence that goes beyond observations by 26 
immunostaining and ChIP-Seq. Herein, we describe a new G4-specific fluorescent probe (SiR-27 
PyPDS) that has properties that enable single-molecule detection of G4s. We use SiR-PyPDS to 28 
achieve real-time detection of individual G4 structures in living cells. Live-cell single-molecule 29 
fluorescence imaging of G4s is carried out under conditions that use low concentrations of the 30 
G4-binding fluorescent probe (20 nM) that enabled us to provide informative measurements 31 
representative of the population of G4s in living cells, without globally perturbing G4 formation 32 
and dynamics. Single-molecule fluorescence imaging and time-dependent chemical trapping of 33 
unfolded G4s in living cells by means of DMS treatment, revealed that G4s fluctuate between 34 
folded and unfolded states. We also demonstrated that G4-formation in live cells is cell-cycle 35 
dependent and inhibited by chemical inhibition of transcription and replication. The observation 36 
of single fluorescent probes binding to individual G4s provides a new experimental perspective 37 
on G4-formation and dynamics in living cells. Our imaging approach will help elucidate the 38 






G-quadruplexes (G4s) are non-canonical structures that can form within guanine-rich nucleic acid 43 
sequences (Fig. 1A)1,2. Sequencing of G4s in human genomic DNA (G4-Seq) revealed over 44 
700,000 distinct sites that can form G4s, with notable G4-enrichment within gene promoters and 45 
at loci commonly amplified in cancers3. G4 structures have also been imaged ex vivo by 46 
immunofluorescence with G4-selective antibodies, both in fixed ciliates4 and, more recently, in 47 
fixed human cells5. The G4-selective antibody BG4 has been used in chromatin immuno-48 
precipitation followed by sequencing (ChIP-Seq), showing that just ~1% of the G4s identified in 49 
purified DNA by G4-Seq could be detected within chromatin6. ChIP-Seq experiments rely on 50 
measurements integrated over millions of cells and therefore provide only an average view of G4-51 
incidence at a given genomic loci. However, G4 homeostasis in cells is likely to be regulated by 52 
proteins, such as helicases, so ex vivo techniques that provide a snapshot of G4 distribution may 53 
hide important dynamic processes that can only be observed by live-cell imaging. Fluorogenic 54 
G4-binding probes for the detection of both RNA7,8 and DNA9,10 G4s in living cells have been 55 
reported. Generally, such probes are used at relatively high (µM) concentrations which can result 56 
in global induction of G4-structures, perturbation of endogenous G4-folding dynamics and 57 
cellular stress/toxicity through binding to G4s globally. Furthermore, some observational 58 
approaches require environmentally responsive probes which can pose limits on the quantitative 59 
study of specific G4-formation as well the challenge of disentangling genuine G4-binding from 60 
environmental effects. We have pursued single-molecule fluorescence imaging of G4s in living 61 
cells to detect individual G4s in the nucleus of living cells at low nanomolar concentrations of 62 
fluorescent probe. The use of a G4-specific probe (SiR-PyPDS) and a control probe (SiR-63 
iPyPDS), with poor affinity to G4s, together with ligand competition experiments, confirmed G4s 64 
specificity. Relatively low probe concentrations (nM) helps avoid global induction of G4s 65 
inherent in ensemble fluorescence methods. Specifically, only a small fraction (~4%) of G4s are 66 
bound by the probe, without perturbing global folding dynamics. Herein we report, for the first 67 
time, detection of individual G4s in the nucleus of living human cells by single-molecule 68 
fluorescence microscopy. 69 
Results and Discussion 70 
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SiR-PyPDS (Fig. 1B) was prepared by tethering the red fluorophore Silicon-Rhodamine (SiR)11 71 
to an analogue of an established G4-ligand, pyridostatin12 (PyPDS), using linkers of different 72 
lengths (Fig. S1 and S2). Upon binding to G4-folded oligonucleotides all SiR-PyPDS analogues 73 
(Fig. S2) displayed a modest fluorescence increase (~10 fold), which is insufficient to confidently 74 
discriminate bound vs unbound probes in cells, but enabled evaluation of optimal linker length by 75 
fluorescence titrations. Binding titrations revealed the six carbon linker of SiR-PyPDS (Fig. 1B) 76 
as being optimal for G4-binding selectivity of the PyPDS-scaffold, with good binding towards 77 
MYC and KIT-1 and h-TELO G4s with Kd values of 0.63 (± 0.08) µM, 1.0 (± 0.1) µM and 2.0 (± 78 
0.8) µM respectively, and no detectable binding to double- or single-stranded DNA (Fig. S3). 79 
SiR-PyPDS displayed a quantum yield of 0.05 in solution that increases to 0.2 when the molecule 80 
is bound to MYC G4 (see methods). We also designed and synthesized a novel PyPDS isomer 81 
(SiR-iPyPDS, Fig. 1B) that could act as a poor-G4 binding control in live cells experiments to 82 
support unambiguous identification of G4-binding events of SiR-PyPDS. Our control analogue 83 
(SiR-iPyPDS) differs from SiR-PyPDS simply for the position of the amino side-chains on the 84 
quinoline ring. We reasoned that the steric clash of the side-chains in SiR-iPyPDS could prevent 85 
the molecule from adopting the flat conformation required for G-tetrad recognition. Fluorescence 86 
titrations confirmed a more than 10-fold lower G4-binding affinity of SiR-iPyPDS compared to 87 
SiR-PyPDS (Fig. S4). 88 
Given the promising results from ensemble binding experiments by SiR-PyPDS and the negative 89 
control analogue SiR-PyPDS, we decided to evaluate the suitability of these probes for single-90 
molecule detection of G4s in vitro. To test this, we investigated the binding of SiR-PyPDS or 91 
SiR-iPyPDS to a G4-folded oligonucleotide, MYC, immobilized on a PEG/biotin-coated surface, 92 
by single-molecule imaging (Fig. 1C-E). We acquired images with a long exposure time (500 ms) 93 
to capture only relatively long-lived interactions. At a much lower ligand concentration than what 94 
was used in ensemble experiments (250 pM), we could detect on average 867 long-lived SiR-95 
PyPDS spots (Fig. 1F, Supplementary Movie S1) in each field of view (Fig. 1G), but observed a 96 
ten-fold reduction in long-lived binding (66 events, P = 5×10-6) for the weaker G4 binder SiR-97 
iPyPDS (Fig. 1I, Supplementary Movie S1). We confirmed that events represented binding of 98 
individual probes to MYC by observing single-step photobleaching (Fig. S5). As the MYC 99 
sequence was also labelled with Alexa Fluor 488 we could use both FRET (Fig. S6A) and single-100 
molecule FRET (Fig. S6B-D) to visualize direct binding of our probe to MYC. Note that at 250 101 
pM, the labelled fraction, , of G4s is about 0.05%, according to the Hill-Langmuir equation  102 = [ ]/ + [ ] , where [ ] is the concentration of ligand and  is the dissociation constant 103 
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for ligand binding to G4s. To further investigate if the number of SiR-PyPDS binding event 104 
correlates with the density of G4 targets immobilized on the surface, we varied the surface 105 
coverage by mixing the biotinylated MYC G4 with a biotinylated single-stranded DNA strand 106 
that does not form a G4, at different ratios (Fig. S7, see Methods). We observed a linear 107 
relationship between the number of SiR-PyPDS binding events detected and the concentration of 108 
MYC G4 immobilised on the surface, confirming that the number of binding events is 109 
proportional to the number of G4s on the surface (Fig. S7) and that this number can be used as a 110 
proxy for G4-density. We have also confirmed that the MYC sequence used is folded into a G4 111 
structure as judged by circular dichroism spectroscopy (Fig. S8). The observed number of binding 112 
events can therefore be used to assess the concentration of folded G4s on the surface. We next 113 
compared the binding of SiR-PyPDS and SiR-iPyPDS to different G4-folding oligonucleotides, 114 
including MYC, h-TELO and c-KIT-1. Again, we observed a >20-fold increase in the number of 115 
binding events for SiR-PyPDS when compared to the control probe SiR-iPyPDS (Fig. S9). These 116 
observations confirm that SiR-PyPDS can be applied to single-molecule imaging of G4s and that 117 
the decreased binding affinity of the control analogue SiR-iPyPDS causes a lower number of 118 
binding events observed (Fig. S9). 119 
To further validate that long-lived binding events observed with SiR-PyPDS could be ascribed as 120 
G4-specific, we attempted to compete out SiR-PyPDS binding to MYC G4 with an excess of the 121 
structurally unrelated G4-binding ligand PhenDC313. Gratifyingly, binding of SiR-PyPDS to 122 
MYC was abrogated when an excess (10 µM) of the potent G4-ligand PhenDC3 was included as 123 
a competitor (16 events, P = 2×10-6, Fig. 1F, Supplementary Movie S2).  Furthermore, we 124 
measured the number of binding events displayed by SiR-PyPDS when the G4-folding sequence 125 
of MYC was mutated to prevent G4-formation. SiR-PyPDS binding was negligible (23 events, P 126 
= 2×10-6) for the immobilized single-stranded DNA control (MYC-mut, Fig. 1F, Supplementary 127 
Movie S1), which is in agreement with what was observed for SiR-PyPDS ensemble fluorescence 128 
titrations (Fig. S3). Both the biotin-MYC and MYC-mut used in this experiment were also 129 
functionalized with an Alexa-488 fluorophore. We used the 488 emission to measure the total 130 
fluorescence on each coverslip functionalised with either MYC or MYC-mut to ensure 131 
comparable density of oligonucleotides on the surface between the different experiments (σ = 132 
10% variation between coverslips, Fig. S7B). Therefore, differences observed in binding events 133 
were minimally affected by variations in G4 surface coverage, confirming the suitability of SiR-134 
PyPDS and SiR-iPyPDS control as probes for the single-molecule detection of G4s.  135 
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We next sought to determine whether the conditions of relatively low probe concentrations used 136 
for single-molecule imaging caused global induction of G4-folding or perturbation of G4-folding 137 
dynamics. To investigate this, we used G4-folding oligonucleotides (MYC, h-TELO and c-KIT1) 138 
labelled with a Cy5 fluorophore at their 5’ end and having an overhang hybridised with a 139 
complementary oligonucleotide sequence containing a Cy3 fluorophore at its 3’ end. The 140 
oligonucleotides form a Cy3-Cy5 FRET system capable of assessing the fraction of folded G4s 141 
by measuring FRET efficiency between the two fluorophores14. When titrated with increasing 142 
concentrations of PyPDS, no significant FRET perturbation was observed for PyPDS 143 
concentrations below 3 µM (Fig. S10). Therefore, there is no detectable global induction of G4s 144 
when imaging under single molecule conditions (Fig 1J). We studied G4-unfolding dynamics 145 
using a FRET system with FAM/TAMRA labelled oligonucleotides that were annealed in 150 146 
mM K+ to form a stable G4 structure (see Methods). We next added a 10 folds molar excess of 147 
DNA sequence complementary to the G4-folding sequence to irreversibly trap the unfolded G4 148 
sequence as dsDNA. This allowed us to measure the unfolding kinetics by monitoring a 149 
concomitant decrease in the FRET fluorescence signal, as previously described14. We found that 150 
µM concentrations of SiR-PyPDS are required to slow down the unfolding rate for the tested G4s 151 
structures and that low nM concentrations used for single-molecule experiments do not globally 152 
affect the unfolding rate of the tested G4-structures (Table S1). Our data demonstrate that single-153 
molecule imaging can be used to address the pervasive problem of current G4-detection strategies 154 
that use relatively high concentrations of affinity probes that might globally perturb G4 folding 155 
and dynamics.           156 
We next applied the fluorescent G4-ligands to single-molecule imaging of G4s in live cells (Fig. 157 
2A). First, we investigated the toxicity of SiR-PyPDS and SiR-iPyPDS in U2OS cells over a 24 h 158 
treatment at different probe concentrations. Both SiR-PyPDS and SiR-iPyPDS did not elicit any 159 
cell death response at nM concentrations, as toxicity could only be observed at concentrations 160 
higher than 10 µM (Fig. S11). Based on this, U2OS cells were treated for 30 min with 20 nM of 161 
SiR-PyPDS, which resulted in under-labeling of G4s at a density where individual fluorophores 162 
were spatially well separated (Fig. 2B). This allowed us to visualize individual probes (SiR-163 
PyPDS or SiR-iPyPDS) binding to targets in the nucleus (Fig. 2B-C, Supplementary Movie S3) 164 
using single-molecule imaging (400 frames taken with 100 ms exposure using highly inclined 165 
laminated optical sheet (HILO) microscopy)15. Single step photobleaching provided evidence of 166 
binding events by individual probe molecules in the nucleus (Fig. S12), in spite of the extra-167 
nuclear lysosomal accumulation of SiR-PyPDS (Fig. S13). We first measured the number of 168 
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binding events whereby a SiR-PyPDS molecule remained stationary within a 300 nm radius for 169 
three or more consecutive frames (i.e. 300 ms), detecting an average of 79 binding events per 170 
nuclei (Fig. 2D). Similarly to what was observed in vitro, treatment of U2OS cells with SiR-171 
iPyPDS (20 nM) revealed an average of only 2 long-lived binding events in the nucleus (Fig. 2D). 172 
To confirm that differences in the number of nuclear binding events between SiR-PyPDS and 173 
SiR-iPyPDS were not due to different cellular uptake of the two ligands, we used confocal 174 
microscopy and demonstrated that upon 10 µM ligands treatment the total nuclear fluorescence 175 
intensity measured was comparable between the SiR-PyPDS and SiR-iPyPDS treatments (Fig. 176 
S14). These results are consistent with the in vitro observations (Fig. 1F) and corroborate the 177 
hypothesis that long-lived SiR-PyPDS binding events could be ascribed to specific G4-binding in 178 
cells. To further support this hypothesis, we demonstrated that SiR-PyPDS binding could be 179 
abrogated in the presence of 10 µM of the unlabeled competitor G4-ligands PDS12 or PhenDC313 180 
(Fig. S15, Supplementary Movie S4), which is also consistent with what was observed in vitro.  181 
We next sought to estimate the fraction of G4-labelled by SiR-PyPDS in living cells as we have 182 
done for the in vitro studies. To do so, we have assumed that the Kd of SiR-PyPDS remains 183 
unchanged in the cellular environment and that the nuclear concentration of the probe is 20 nM. 184 
Based on these assumptions and using the relationship [ ]/ + [ ] , the fraction of labelled 185 
G4s on a single U2OS cells is around 4%. Using this value for labelled G4 fraction, we have 186 
roughly estimated the total number of G4s present in a single cell.  As we detect about 10 binding 187 
events on average in an image frame within a single focal plane (~ 1µm), there would be around 188 
100 binding events in an entire U2OS cell of diameter ~ 10 µm. Therefore, considering we are 189 
labelling around 4% of the total number of targets, we can estimate a total number of G4s in a 190 
single cell of ~3000, which is in line with what has been detected in human chromatin (between 191 
1,000 and 10,000 G4s) by G4-ChIP-Seq experiments.6  192 
We then compared the temporal dynamics of the interaction between SiR-PyPDS and G4s in vitro 193 
and in cells, to investigate if characteristic dwell times of SiR-PyPDS binding to G4s in vitro 194 
could also be detected in cells. Time-lapse imaging was used to observe long-lived events (Fig. 195 
3A, Supplementary Movie S5). In vitro, an exposure time of 100 ms and interval of 2 s was used 196 
to avoid photobleaching effects (time constant τb = 923 s), whereas for cellular experiments a 197 
slightly longer interval (3 s, τb = 104 s) and also a longer exposure time (500 ms) were needed to 198 
limit contributions from unbound ligands16. The histogram of SiR-PyPDS dwell times could be 199 
well fitted (R2 > 0.99) to a single exponential distribution, yielding a photobleaching-corrected 200 
binding lifetime of 6.6±0.5 s in cells (Fig. 3B), which is significantly shorter (~2.5 folds, P = 201 
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4×10-7, unpaired t-test) than that observed in vitro for binding (15.4±0.6 s) to MYC G4. To 202 
investigate further this apparent discrepancy, we carried out in vitro binding experiments with 203 
other G4-forming sequences. These experiments indicated that the dwell times for SiR-PyPDS 204 
binding to hTelo and c-KIT1 were respectively 2.5 and 2 times shorter than MYC and were 205 
comparable to dwell times observed in living cells. These experiments suggested that the binding 206 
dynamics of SiR-PyPDS to synthetic G4-forming oligonucleotides observed in vitro can be 207 
recapitulated in cells, further supporting that our assay can detect endogenous G4s. 208 
To gain insight into G4-folding dynamics in living cells, we employed the DNA-methylating 209 
agent dimethyl-sulfate (DMS) to irreversibly trap the unfolded G4 state (Fig. 3C). The 210 
nucleophilic N7 atoms of guanines are exposed and can be methylated by DMS in single- and 211 
double-stranded DNA, but are protected in folded G4s by their participation in Hoogsteen 212 
hydrogen bonding (Fig 1A). Thus, transiently unfolded G4s can be methylated and irreversibly 213 
prevent further G4 re-folding by blocking Hoogsteen hydrogen bonding at N7s (Fig. 3C). First, 214 
we demonstrated that DMS could trap the unfolded G4 state in vitro by quantifying binding 215 
events of SiR-PyPDS with MYC prior to (300 events) and after (40 events, P = 0.03) 20 min 216 
treatment with 640 mM (8%) DMS (Fig. 3D). We then examined if a similar DMS-dependent G4 217 
depletion could be recapitulated in living cells, while keeping the DMS concentration lower (20 218 
mM, 0.25%) to prevent cell death. We observed a time-dependent decrease of SiR-PyPDS 219 
binding events in U2OS cells within minutes after DMS treatment (Fig 3E, Supplementary Movie 220 
S6), with a ~20-fold reduction (P = 0.006) in binding events after 20 min exposure. These results 221 
suggest that G4s naturally undergo structural fluctuations in cells. This, in turn, makes their 222 
specific detection by chemical methods, such as DMS-Seq17, ineffective, as they will inevitably 223 
trap the unfolded state (Fig. 3C).  224 
We further probed dynamic formation of G4s in live U2OS cells through different phases of the 225 
cell cycle to gain insights into changes in G4-prevalence during active DNA processing states, 226 
such as replication (S phase) and transcription (G1 phase). We first confirmed using confocal 227 
microscopy that under different conditions tested there were negligible differences in uptake of 228 
the fluorescent G4 ligand (Fig. S14). This ensured that the lack of binding events observed under 229 
certain cycle phases or after DMS treatment could be confidently ascribed to a change in G4 230 
prevalence. SiR-PyPDS-treated U2OS cells were synchronized to S, G1/S and G0/G1 phases 231 
using previously reported procedures4 and imaged using single-molecule fluorescence 232 
microscopy. During S phase, where the cell is undergoing active replication, significant (P < 10-6) 233 
binding events could be detected (208 events, Fig. 4A, Supplementary Movie S7). The number of 234 
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binding events was slightly reduced (103 events, P = 0.01) when cells are preparing to initiate 235 
replication (G1/S phase) and transcription is active (Fig. 4B, Supplementary Movie S7). There 236 
were negligible (P < 10-6) binding events during G0/G1 phase (3 events, Fig. 4C, Supplementary 237 
Movie S7), where cellular processes are quiescent. These results show that G4 formation is 238 
associated with both transcription and replication and is in agreement with previous observations 239 
reported in fixed cells4,18. To further confirm the suppression of G4s in the absence of actively 240 
processed DNA, we treated unsynchronized U2OS cells with a global replication inhibitor 241 
aphidicolin and also the global transcription inhibitor DRB as previously described17, in order to 242 
mimic the quiescent state that characterizes cells undergoing G0 phase. Upon transcription and 243 
replication arrest few binding events were detected (3 events, P < 10-6), further demonstrating that 244 
actively processed DNA is pivotal for G4 formation in living cells (Fig. 4C-D, Supplementary 245 
Movie S7).  246 
Conclusions 247 
We have used fluorescent probe molecules to visualise individual G4 structures in living cells, for 248 
the first time, using single-molecule fluorescence imaging. The sensitivity of single-molecule 249 
methods enabled us to image single binding events to G4 structures at probe concentrations 250 
orders of magnitude lower than normally used in biophysical and cellular experiments, thereby 251 
minimizing global perturbation of G4s. We applied our new imaging platform to demonstrate that 252 
G4-formation is cell-cycle dependent and that the presence of G4s is directly related to 253 
fundamental biological processes such as active transcription and replication, as chemical 254 
inhibition of these processes led to abrogation of detectable G4s in living cells. Trapping of 255 
unfolded G4s by means of DMS methylation revealed that G4s undergo dynamic fluctuations in 256 
live cells and that essentially all G4s are trapped in the unfolded state during the course of 20 min 257 
DMS treatment (0.25%, 20 mM). We anticipate that further application of this imaging platform 258 
will help unravel specific biological functions regulated by individual G4s within the human 259 
genome in real-time.  260 
Supplementary Information is available in the online version of the paper. 261 
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Figure 1. In vitro single-molecule fluorescence imaging of G-quadruplexes. (A) Schematic 283 
representation of a G-tetrad (left) and a G4 structure (right). (B) Chemical structure of the 284 
selective G4-fluorogenic ligand SiR-PyPDS (left) and its inactive isomer, SiR-iPyPDS (right). 285 
(C) Schematic of methodology used for visualizing individual G4s. Pre-folded G4 MYC is 286 
attached to a coverslip via a biotin-neutravidin linker. The fluorescent G4-probe SiR-PyPDS 287 
binds to G4 MYC, which can be visualized using single-molecule fluorescence imaging. (D) SiR-288 
PyPDS will not bind single stranded mutated-MYC that cannot form a G4. (E) The inactive 289 
isomer SiR-iPyPDS with its 10 times reduced binding affinity is less likely to bind G4 MYC. (F) 290 
Quantification of SiR-PyPDS binding to the G4 MYC ii) SiR-PyPDS binding to the mutated-291 
MYC; iii) SiR-iPyPDS binding to the G4 MYC; iv) SiR-PyPDS binding to the G4 MYC in the 292 
presence of 10 µM unlabeled PhenDC3 competitor. Error bars indicate mean ± sd. *** P < 10-5, 293 
unpaired t-test.  (G) Representative images (500 ms exposure) of individual SiR-PyPDS 294 
molecules (250 pM) binding to a surface coated with pre-folded MYC G4 oligonucleotide; 295 
individual fluorescent puncta indicate binding of single SiR-PyPDS molecules. (H) SiR-PyPDS 296 
(250 pM) binding to mutated-MYC. (I) SiR-iPyPDS (250 pM) binding to pre-folded MYC. (J) 297 







































































































































Changes in the FRET ratio can be observed at µM PDS concentrations for Kit1 and hTelo and 299 




Figure 2. Single-molecule fluorescence imaging of G-quadruplexes in living cells using the 304 
fluorescent probe SiR-PyPDS. (A) Schematic of G4s in the cell nucleus with a zoom-in 305 
showing G4s stained by SiR-PyPDS. (B) Representative background-subtracted image (max 306 
projection of 100 frames with 200 ms exposure) of SiR-PyPDS binding events in a living U2OS 307 
cell treated with 20 nM SiR-PyPDS for 30 min before imaging; fluorescent puncta indicate 308 
binding of single SiR-PyPDS molecules. Blue color corresponds to nuclear staining with Hoechst 309 
33342. Scale bar is 2 µm. Inset scale bar is 1 µm. C) Representative image of SiR-iPyPDS 310 
staining in living U2OS cell treated with 20 nM SiR-PyPDS for 30 min before imaging. (D) 311 
Quantification of the binding events within the nucleus lasting more than one frame (100 ms per 312 
frame) per cell for SiR-PyPDS and SiR-iPyPDS. Center lines indicate the median; boxes show 313 




Figure 3. G-quadruplexes in living cells undergo dynamic folding/unfolding. (A) Single-316 
molecule time-lapse imaging of SiR-PyPDS in vitro (top) and in cells (bottom). Individual images 317 
from the time-lapse stack are shown on the left and kymographs on the right show the dynamic 318 
binding kinetics of SiR-PyPDS to G4s. (B) The histograms of dwell times for each experiment (3 319 
positions on a cover slip for in vitro and 6 cells for the cell experiment) were fitted with a single-320 
exponential fit to determine the binding lifetime in each condition. (C) Schematic of DMS-321 
meditated chemical trapping of unfolded G4s. (D) Quantification of G4-binding events for 322 
untreated and 600 mM DMS-treated G4 MYC for 20 min. Error bars indicate mean ± sd. * P < 323 
0.05, Mann-Whitney U-test. (E) Quantification of G4-binding events detected in living cells upon 324 
increased exposure to DMS (20 mM), showing a clear time-dependent depletion of G4s. Center 325 
lines indicate the median; boxes show interquartile range; whiskers denote 5th and 95th 326 








Figure 4. The observation of G4s in live cells is altered by the cell cycle phase and 333 
transcription. Representative single-molecule images of G4-binding events are shown for 334 
synchronized U2OS cells in (A) the S phase, (B) the G1/S phase, (C) the G0/G1 phase and (D) 335 
for unsynchronized cells treated with both the transcriptional inhibitor DRB and the replication 336 
inhibitor Aphidicolin. (E) Quantification of binding events lasting more than two frames (100 ms 337 
per frame) per cell in living U2OS cells at different cell-cycle phases and after 338 
transcription/replication arrest. Center lines indicate the median; boxes show interquartile range; 339 





Detailed synthetic protocols and purification methodologies for the preparation of SiR-PyPDS 345 
and SiR-iPyPDS, biophysical methods and more detailed protocols are described in supporting 346 
information.  347 
 348 
In vitro single-molecule fluorescence imaging  349 
Binding of G4 ligands to synthetic biotinylated oligonucleotides was imaged at single-molecule 350 
resolution by total internal reflection fluorescence microscopy (TIRFM) on glass coverslips 351 
coated with polyethylene glycol (PEG) and NeutrAvidin. In this study, we used two different 352 
PEG coating procedures (see SI): one based on passive adsorption (Coating method 1, used for 353 
data in Fig. 1, 3 and S5) and the other on covalent coupling (Coating method 2, used for data in 354 
Fig. S6, S7 and S9). We found similar surface densities of immobilized biotinylated 355 
oligonucleotides and degrees of non-specific binding on each surface. Buffers for surface 356 
treatment and imaging were freshly filtered each day (0.02 μm syringe filter, Whatman, Cat. No. 357 
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6809–2101). Each biotinylated surface was then treated in the same way prior to single-molecule 358 
imaging. Wells were first coated with 10 µL of 0.2 mg/mL NeutrAvidin (ThermoFisher, Cat. No. 359 
31000) in 1x PBS containing 0.05% tween-20 for 5 min, washed twice with 10 µL of 1x PBS 360 
containing 0.05% tween-20, then treated with 10 µL of 1x PBS containing 1% tween-20 for 10 361 
min. Biotinylated oligonucleotides (c-MYC or c-MYC-mutant, annealed overnight at 100 nM 362 
concentration in 100 mM KCl and 50 mM KH2PO4, pH 7.4) were then diluted to 10 nM in 1x 363 
PBS containing 0.05% tween-20 and 10 µL added to each well for 5 min. The wells were then 364 
washed twice with 10 µL of 1x PBS containing 0.05% tween-20, then treated with 10 µL of 1x 365 
PBS containing 1% tween-20 for 10 min. The wells were then washed once with 250 pM of G4 366 
ligand solutions (SiR-PyPDS or SiR-iPyPDS) in PBS and the solution was finally replaced with 9 367 
µL of G4 ligand at 250 pM in PBS. For in vitro ligand displacement experiments, 1 µl of 1mM 368 
PhenDC3 was added to the well. For DMS trapping the pre-annealed MYC oligonucleotide (100 369 
nM) was treated with DMS 8% for 20 minutes, quenched by adding 10% β-mercapto-ethanol and 370 
used for surface coating. 371 
 372 
The general setup used for TIRFM has been described previously19. For the in vitro experiments 373 
TIRFM was implemented on a Nikon Eclipse Ti2 inverted microscope with a Perfect Focus 374 
System for maintaining focus during acquisition. 488 nm (MLD 488-200, Cobolt) and 640 nm 375 
(LBX-638-180-CSB-PP, Oxxius) lasers were used for excitation with clean-up filters. The 376 
emission collected by the 1.49 NA oil immersion 60× (90× with internal magnification) objective 377 
lens (Nikon) was filtered with long-pass and band-pass filters (520/36 – 67030 and 692/40 – 378 
67038, Edmund Optics) and imaged on an Evolve 512 Delta EMCCD (Photometrics) with a pixel 379 
size of 178 nm, confirmed using a Ronchi ruling. The excitation power density was measured by 380 
determining the excitation power after the objective and the beam size in the imaging plane, 381 
taking ~4-fold near-field enhancement into account. For binding event measurements, a field of 382 
view was acquired for each condition with 500 ms exposure time at a power density of 1.4 383 
kW/cm2. For longer residency time measurements, time lapses of 300 frames were acquired every 384 
2 s with an exposure time of 100 ms and a power density of 0.4 kW/cm2. For shorter residency 385 
time measurements, time lapses of 300 frames were acquired every 100 ms with an exposure time 386 
of 100 ms and a power density of 0.4 kW/cm2. 387 
 388 
Live Cell Imaging  389 
In a typical experiment ~200.000 U2OS cells diluted in 2 ml of DMEM were plated in a 35 mm 390 
dish with a 14mm Glass coverslip at the bottom (MatTek) and allowed to adhere overnight. After 391 
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~18h, the media was replaced with 2 ml of fresh DMEM media containing SiR-PyPDS or SiR-392 
iPyPDS at a final concentration of 20 nM and cells where further incubated for 30 min. The 393 
DMEM media containing SiR molecules was then discarded and cells were washed 2X with PBS 394 
pre-warmed at 37 °C. Finally, the media was replaced with PBS containing Hoechst 2µM for 395 
nuclear staining, pre-warmed at 37 °C, which was immediately followed by imaging.  396 
The effect of DMS on cellular G4 prevalence was evaluated by treatment prior to SiR-PyPDS 397 
labelling: cells were incubated with DMEM containing 20 mM DMS for the indicated time (5, 10 398 
or 20 min). After the desired treatment time DMS was quenched by adding 10% β-mercapto-399 
ethanol in PBS followed by 2X washing with PBS pre-warmed at 37 °C. 400 
Cell cycle synchronisation was performed with mimosine treatment as previously described4. 401 
Transcriptional and replication arrest was achieved by co-treatment of cells with DRB and 402 
Aphidicolin as previously described17.    403 
 404 
Binding of SiR-PyPDS to nuclear G4s was visualised using highly inclined laminated optical 405 
sheet (HILO) microscopy15. The microscope setup used has been described previously20. The 406 
central plane of the nucleus in U2OS cells was found with either bright-field microscopy or using 407 
Hoechst staining. For binding event measurements, 400 frames were acquired for each cell with 408 
100 ms exposure time at a power density of 180 W/cm2. For residency time measurements, time 409 
lapses of 70 frames were acquired every 3 s with an exposure time of 500 ms and a power density 410 
of 180 W/cm2. 411 
 412 
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